| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:26545148 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:27871981 |
| GO:0002524 | Hypersensitivity | Increases phenotype | PMID:27871981 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:27871981 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:32387388; PMID:37364641 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:35739755 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:26545148 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:29410257 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:32518293 |
| GO:0036269 | Swimming behavior | Affects phenotype | PMID:32518293 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:35739755; PMID:37364641 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:27871981 |
| GO:0046622 | Positive regulation of organ growth | Increases phenotype | PMID:32518293 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:37364641 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:32387388 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:37364641 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:32518293 |
| GO:0098743 | Cell aggregation | Increases phenotype | PMID:32387388 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:35739755 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:35739755 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:27871981 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:37364641 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:37364641 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.